Exosens acquires Emberion
Exosens completed the acquisition of Emberion, a Finland- and UK-based company specializing in the design and manufacturing of innovative infrared sensors leveraging patented quantum dot imaging technology. This acquisition strengthens Exosens’ position as a leading provider of advanced imaging technologies across the full spectrum of light, with the addition of emerging quantum dot-based short-wave infrared (SWIR) sensors, unlocking new growth opportunities in the defense and surveillance markets, particularly for portable and drone-based imaging systems, as well as in industrial control applications such as semiconductor inspection.
Emberion technology originated from research activities at Nokia and was acquired by Verso Capital and the management team to form Emberion in 2016. Over the past years Emberion evolved from a material sciences company to a product company with a fully in-house designed SWIR camera offering and a strong customer base across various industries. Emberion became the only European colloidal quantum dot SWIR company with a full in-house developed technology stack including several variants of quantum dot sensors built on Emberion’s own IC, and in-house developed camera SW and HW. Emberion’s unique technology is protected by over 120 granted patents world-wide.
”Combining Emberion’s patented technology with Exosens’ existing offering, sales channel and large-volume manufacturing capability enables true large-scale global deployment of Emberion’s unique technology,” says Anssi Kariola, chairman of the board at Emberion and Managing Partner at Verso Capital. “We believe this acquisition provides an optimal path for Emberion to take the next growth step.”
Emberion was part of the Verso Capital investment portfolio and other large shareholders included Tesi and Nidoco Ab.
About Verso Capital
Verso Capital is a Nordic private equity company investing in profitable European B2B businesses with €10-100m in revenue. We specialize in carve-outs and buy-out situations where we can leverage our extensive operational and carve-out experience to build market-leading companies with sustainable profitable growth. Our team has experience from over 100 carve-out and M&A transactions – we have the necessary know-how and methodology to execute even complicated transactions quickly and efficiently. We invest primarily in northern Europe and have offices in Helsinki, Stockholm and Frankfurt.
www.versocapital.com
Media contact: Anssi.kariola@versocapital.com
About Exosens
Exosens is a high-tech company, with more than 85 years of experience in the innovation, development, manufacturing and sale of high-end electro-optical technologies in the field of amplification, detection and imaging. Today, it offers its customers detection components and solutions such as advanced cameras, neutron and gamma detectors, instrument detectors and light intensifier tubes. This allows Exosens to respond to complex issues in extremely demanding environments by offering tailor-made solutions to its customers. Thanks to its sustained investments, Exosens is internationally recognized as a major innovator in optoelectronics, with production and R&D carried out on 12 sites, in Europe and North America, and with over 2,000 employees. Exosens is listed on compartment A of Euronext Paris regulated market (Ticker: EXENS; ISIN: FR001400Q9V2). Exosens is a member of Euronext Tech Leaders segment and is also included in several indices, including SBF 120, CAC All-Tradable, CAC Mid 60, FTSE Total Cap and MSCI France Small Cap.